Preoperative combined radiochemo-moleculartargettherapy of the locally advanced rectum carcinoma (cT3NxM0) - a phase II pilot study with preoperative application of capecitabine, bevacizumab and radiotherapy (RTx)

Trial Profile

Preoperative combined radiochemo-moleculartargettherapy of the locally advanced rectum carcinoma (cT3NxM0) - a phase II pilot study with preoperative application of capecitabine, bevacizumab and radiotherapy (RTx)

Discontinued
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2011

At a glance

  • Drugs Bevacizumab; Capecitabine
  • Indications Colorectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Mar 2009 Actual initiation date changed from May 2008 to Jul 2008 as reported by ClinicalTrials.gov.
    • 12 Mar 2009 Actual patient number (8) added as reported by ClinicalTrials.gov.
    • 12 Mar 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top